Comparative Effectiveness Will Likely Move To Cost Matters, Speakers Say
This article was originally published in The Gray Sheet
Executive Summary
Industry efforts to restrict comparative effectiveness research from morphing into outright cost comparisons might be a losing battle, some speakers at last week's AdvaMed meeting suggested